Search research articles
Contact Us
Filters
Showing results (121-130 of 302) with videos related to
Page
of 31
Sort By:
Circulation
|
May 23, 2007
Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation
Gregg W Stone, Stephen G Ellis, Antonio Colombo, et al.
Journal of the American College of Cardiology
|
May 7, 2013
Severe aortic stenosis and coronary artery disease--implications for management in the transcatheter aortic valve replacement era: a comprehensive review
Sachin S Goel, Mobolaji Ige, E Murat Tuzcu, et al.
The Journal of Invasive Cardiology
|
October 2, 2007
Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study
Stephen G Ellis, David Kandzari, Dean J Kereiakes, et al.
JACC. Cardiovascular Interventions
|
June 23, 2009
Characterization of post-operative risk associated with prior drug-eluting stent use
Saif Anwaruddin, Arman T Askari, Hammad Saudye, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 29, 2015
Management of drug eluting stent in-stent restenosis: A systematic review and meta-analysis
Sachin S Goel, Rama Dilip Gajulapalli, Ganesh Athappan, et al.
The Canadian Journal of Cardiology
|
August 14, 2003
Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting
Philippe L L'Allier, Herbert D Aronow, Fernando A Cura, et al.
The American Journal of Cardiology
|
January 17, 2012
Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention
Dharam J Kumbhani, Mehdi H Shishehbor, Joshua M Willis, et al.
The American Journal of Cardiology
|
September 26, 2006
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes
Juhana Karha, Hitinder S Gurm, Vivek Rajagopal, et al.
The American Journal of Cardiology
|
July 28, 2004
Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention
Deepak P Vivekananthan, Deepak L Bhatt, Derek P Chew, et al.
JACC. Cardiovascular Interventions
|
May 21, 2011
Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program
Gregg W Stone, Stephen G Ellis, Antonio Colombo, et al.
Page
of 31
Search research articles
Search
Showing results (121-130 of 302) with videos related to
Sort By:
Page
of 31
Circulation
|
May 23, 2007
Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation
Gregg W Stone, Stephen G Ellis, Antonio Colombo, et al.
Journal of the American College of Cardiology
|
May 7, 2013
Severe aortic stenosis and coronary artery disease--implications for management in the transcatheter aortic valve replacement era: a comprehensive review
Sachin S Goel, Mobolaji Ige, E Murat Tuzcu, et al.
The Journal of Invasive Cardiology
|
October 2, 2007
Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study
Stephen G Ellis, David Kandzari, Dean J Kereiakes, et al.
JACC. Cardiovascular Interventions
|
June 23, 2009
Characterization of post-operative risk associated with prior drug-eluting stent use
Saif Anwaruddin, Arman T Askari, Hammad Saudye, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 29, 2015
Management of drug eluting stent in-stent restenosis: A systematic review and meta-analysis
Sachin S Goel, Rama Dilip Gajulapalli, Ganesh Athappan, et al.
The Canadian Journal of Cardiology
|
August 14, 2003
Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting
Philippe L L'Allier, Herbert D Aronow, Fernando A Cura, et al.
The American Journal of Cardiology
|
January 17, 2012
Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention
Dharam J Kumbhani, Mehdi H Shishehbor, Joshua M Willis, et al.
The American Journal of Cardiology
|
September 26, 2006
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes
Juhana Karha, Hitinder S Gurm, Vivek Rajagopal, et al.
The American Journal of Cardiology
|
July 28, 2004
Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention
Deepak P Vivekananthan, Deepak L Bhatt, Derek P Chew, et al.
JACC. Cardiovascular Interventions
|
May 21, 2011
Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program
Gregg W Stone, Stephen G Ellis, Antonio Colombo, et al.
Page
of 31